DUNHAM TRUST Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
DUNHAM TRUST Co's BMY Position: Q3 2026 in Review
DUNHAM TRUST Co held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 800 shares worth $49.9K. The position accounts for 0.02% of the portfolio, ranked #154.
DUNHAM TRUST Co first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,533 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- DUNHAM TRUST Co held 800 shares of Bristol-Myers Squibb worth $49.9K as of Q3 2026.
- DUNHAM TRUST Co left its Bristol-Myers Squibb share count unchanged in Q3 2026.
- Bristol-Myers Squibb made up 0.02% of DUNHAM TRUST Co's portfolio in Q3 2026, its #154 holding.
- DUNHAM TRUST Co first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,533 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on DUNHAM TRUST Co's 13F filing for Q3 2026, filed 16 Nov 2026.